| Aug 8 |
Immunic GAAP EPS of -$0.21 beats by $0.02
|
| Aug 8 |
Immunic: Q2 Earnings Snapshot
|
| Aug 8 |
Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update
|
| Aug 7 |
Immunic Q2 2024 Earnings Preview
|
| Aug 1 |
Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
|
| Jul 24 |
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec
|
| Jul 9 |
Immunic appoints Jason Tardio as COO and President
|
| Jul 9 |
Immunic Appoints Jason Tardio as Chief Operating Officer and President
|
| Jun 5 |
When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?
|
| May 28 |
Immunic to Participate in Industry and Scientific Conferences in June
|
